Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.36
NAS:ADUS's Cash-to-Debt is ranked higher than
58% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. NAS:ADUS: 0.36 )
Ranked among companies with meaningful Cash-to-Debt only.
NAS:ADUS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.3 Max: No Debt
Current: 0.36
Equity-to-Asset 0.66
NAS:ADUS's Equity-to-Asset is ranked higher than
76% of the 255 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. NAS:ADUS: 0.66 )
Ranked among companies with meaningful Equity-to-Asset only.
NAS:ADUS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.63 Max: 0.76
Current: 0.66
0.25
0.76
Debt-to-Equity 0.26
NAS:ADUS's Debt-to-Equity is ranked higher than
82% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 0.57 vs. NAS:ADUS: 0.26 )
Ranked among companies with meaningful Debt-to-Equity only.
NAS:ADUS' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02  Med: 0.29 Max: 1.83
Current: 0.26
0.02
1.83
Interest Coverage 5.80
NAS:ADUS's Interest Coverage is ranked higher than
50% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 8.41 vs. NAS:ADUS: 5.80 )
Ranked among companies with meaningful Interest Coverage only.
NAS:ADUS' s Interest Coverage Range Over the Past 10 Years
Min: 1.02  Med: 5.83 Max: 25.89
Current: 5.8
1.02
25.89
Piotroski F-Score: 6
Altman Z-Score: 5.58
Beneish M-Score: -2.21
WACC vs ROIC
-0.52%
9.69%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 5.60
NAS:ADUS's Operating Margin % is ranked lower than
60% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. NAS:ADUS: 5.60 )
Ranked among companies with meaningful Operating Margin % only.
NAS:ADUS' s Operating Margin % Range Over the Past 10 Years
Min: 2.59  Med: 4.68 Max: 6.41
Current: 5.6
2.59
6.41
Net Margin % 3.94
NAS:ADUS's Net Margin % is ranked lower than
53% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. NAS:ADUS: 3.94 )
Ranked among companies with meaningful Net Margin % only.
NAS:ADUS' s Net Margin % Range Over the Past 10 Years
Min: -0.86  Med: 2.81 Max: 7.2
Current: 3.94
-0.86
7.2
ROE % 10.26
NAS:ADUS's ROE % is ranked higher than
54% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 9.35 vs. NAS:ADUS: 10.26 )
Ranked among companies with meaningful ROE % only.
NAS:ADUS' s ROE % Range Over the Past 10 Years
Min: -10.67  Med: 7.58 Max: 18.38
Current: 10.26
-10.67
18.38
ROA % 6.77
NAS:ADUS's ROA % is ranked higher than
69% of the 263 Companies
in the Global Medical Care industry.

( Industry Median: 3.85 vs. NAS:ADUS: 6.77 )
Ranked among companies with meaningful ROA % only.
NAS:ADUS' s ROA % Range Over the Past 10 Years
Min: -1.23  Med: 4.34 Max: 12.2
Current: 6.77
-1.23
12.2
ROC (Joel Greenblatt) % 31.69
NAS:ADUS's ROC (Joel Greenblatt) % is ranked higher than
69% of the 263 Companies
in the Global Medical Care industry.

( Industry Median: 16.07 vs. NAS:ADUS: 31.69 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NAS:ADUS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 16.92  Med: 29.03 Max: 43.85
Current: 31.69
16.92
43.85
3-Year Revenue Growth Rate 13.70
NAS:ADUS's 3-Year Revenue Growth Rate is ranked higher than
69% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. NAS:ADUS: 13.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NAS:ADUS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -54.8  Med: 3.4 Max: 13.7
Current: 13.7
-54.8
13.7
3-Year EBITDA Growth Rate 10.90
NAS:ADUS's 3-Year EBITDA Growth Rate is ranked higher than
57% of the 167 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. NAS:ADUS: 10.90 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NAS:ADUS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -52.9  Med: 2.9 Max: 10.9
Current: 10.9
-52.9
10.9
3-Year EPS without NRI Growth Rate 1.30
NAS:ADUS's 3-Year EPS without NRI Growth Rate is ranked lower than
65% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 7.50 vs. NAS:ADUS: 1.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NAS:ADUS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 1.3  Med: 8.7 Max: 35.1
Current: 1.3
1.3
35.1
GuruFocus has detected 1 Warning Sign with Addus HomeCare Corp $NAS:ADUS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NAS:ADUS's 30-Y Financials

Financials (Next Earnings Date: 2017-11-08 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

ADUS Guru Trades in Q3 2016

Jim Simons 50,100 sh (-40.50%)
» More
Q4 2016

ADUS Guru Trades in Q4 2016

Jim Simons 12,300 sh (-75.45%)
» More
Q1 2017

ADUS Guru Trades in Q1 2017

Jim Simons 57,000 sh (+363.41%)
» More
Q2 2017

ADUS Guru Trades in Q2 2017

Jim Simons 43,600 sh (-23.51%)
» More
» Details

Insider Trades

Latest Guru Trades with NAS:ADUS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621610    SIC: 8082
Compare:NAS:BIOS, NAS:SGRY, NYSE:AAC, OTCPK:AVCO, NYSE:QHC, NAS:AFAM, AMEX:HLTH, TSXV:IOM, NAS:PRSC, OTCPK:NVOS, NAS:CATS, NAS:JYNT, OTCPK:AMEH, OTCPK:CCEL, NYSE:USPH, OTCPK:FCHS, OTCPK:MIHI, OTCPK:BICX, TSXV:CXV, AMEX:AMS » details
Traded in other countries:A41.Germany,
Headquarter Location:USA
Addus HomeCare Corp provides home and community based services, which are social in nature and are provided in the home, focused on the dual eligible population.

Addus HomeCare Corp was incorporated in Delaware in 2006 under the name Addus Holding Corporation for the purpose of acquiring Addus HealthCare, Inc. The Company provides home and community based services, which are mainly social in nature and are provided in the home, focused on the dual eligible population. Its services include personal care and assistance with activities of daily living, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, commercial insurers and private individuals. It provides home and community based services through over 121 locations across 21 states to over 26,000 consumers. The home and community based services the company provides are mainly social in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living. It provides these services on a long-term, continuous basis, with an average duration of approximately 17 months per consumer. Its adult day centers provide a comprehensive program of skilled and support services and designated medical services for adults in a community-based group setting. Services provided by Company's adult day centers include social activities, transportation services to and from the centers, the provision of meals and snacks, personal care and therapeutic activities such as exercise and cognitive interaction. The Company competes with home and community based service providers, home health providers, private caregivers, larger publicly held companies, privately held companies, privately held single-site agencies, hospital-based agencies, not-for-profit organizations, community-based organizations, managed care organizations and self-directed care programs. Its business is subject to extensive and increasing federal, state and local regulation.

Ratios

vs
industry
vs
history
PE Ratio 24.18
ADUS's PE Ratio is ranked lower than
51% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 26.05 vs. ADUS: 24.18 )
Ranked among companies with meaningful PE Ratio only.
ADUS' s PE Ratio Range Over the Past 10 Years
Min: 4.55  Med: 21.72 Max: 49.28
Current: 24.18
4.55
49.28
Forward PE Ratio 17.83
ADUS's Forward PE Ratio is ranked lower than
61% of the 62 Companies
in the Global Medical Care industry.

( Industry Median: 21.05 vs. ADUS: 17.83 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 24.34
ADUS's PE Ratio without NRI is ranked higher than
50% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. ADUS: 24.34 )
Ranked among companies with meaningful PE Ratio without NRI only.
ADUS' s PE Ratio without NRI Range Over the Past 10 Years
Min: 2.97  Med: 21.75 Max: 51.52
Current: 24.34
2.97
51.52
PB Ratio 2.32
ADUS's PB Ratio is ranked lower than
51% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 2.54 vs. ADUS: 2.32 )
Ranked among companies with meaningful PB Ratio only.
ADUS' s PB Ratio Range Over the Past 10 Years
Min: 0.38  Med: 1.59 Max: 3.02
Current: 2.32
0.38
3.02
PS Ratio 0.96
ADUS's PS Ratio is ranked higher than
71% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.69 vs. ADUS: 0.96 )
Ranked among companies with meaningful PS Ratio only.
ADUS' s PS Ratio Range Over the Past 10 Years
Min: 0.09  Med: 0.66 Max: 1.32
Current: 0.96
0.09
1.32
Price-to-Free-Cash-Flow 87.09
ADUS's Price-to-Free-Cash-Flow is ranked lower than
65% of the 116 Companies
in the Global Medical Care industry.

( Industry Median: 24.30 vs. ADUS: 87.09 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ADUS' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 1.25  Med: 12.33 Max: 155.97
Current: 87.09
1.25
155.97
Price-to-Operating-Cash-Flow 54.12
ADUS's Price-to-Operating-Cash-Flow is ranked lower than
81% of the 167 Companies
in the Global Medical Care industry.

( Industry Median: 15.16 vs. ADUS: 54.12 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ADUS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.24  Med: 11.75 Max: 92.2
Current: 54.12
1.24
92.2
EV-to-EBIT 16.19
ADUS's EV-to-EBIT is ranked higher than
61% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 20.05 vs. ADUS: 16.19 )
Ranked among companies with meaningful EV-to-EBIT only.
ADUS' s EV-to-EBIT Range Over the Past 10 Years
Min: -11.5  Med: 12.6 Max: 34.7
Current: 16.19
-11.5
34.7
EV-to-EBITDA 12.97
ADUS's EV-to-EBITDA is ranked higher than
57% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 15.41 vs. ADUS: 12.97 )
Ranked among companies with meaningful EV-to-EBITDA only.
ADUS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -23.9  Med: 10.5 Max: 21
Current: 12.97
-23.9
21
EV-to-Revenue 1.03
ADUS's EV-to-Revenue is ranked higher than
78% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. ADUS: 1.03 )
Ranked among companies with meaningful EV-to-Revenue only.
ADUS' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.3  Med: 0.7 Max: 1.2
Current: 1.03
0.3
1.2
PEG Ratio 5.19
ADUS's PEG Ratio is ranked lower than
73% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 3.06 vs. ADUS: 5.19 )
Ranked among companies with meaningful PEG Ratio only.
ADUS' s PEG Ratio Range Over the Past 10 Years
Min: 5.19  Med: 10.79 Max: 41.54
Current: 5.19
5.19
41.54
Current Ratio 3.35
ADUS's Current Ratio is ranked higher than
83% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. ADUS: 3.35 )
Ranked among companies with meaningful Current Ratio only.
ADUS' s Current Ratio Range Over the Past 10 Years
Min: 1.66  Med: 2.22 Max: 3.35
Current: 3.35
1.66
3.35
Quick Ratio 3.35
ADUS's Quick Ratio is ranked higher than
85% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. ADUS: 3.35 )
Ranked among companies with meaningful Quick Ratio only.
ADUS' s Quick Ratio Range Over the Past 10 Years
Min: 1.66  Med: 2.22 Max: 3.35
Current: 3.35
1.66
3.35
Days Sales Outstanding 122.13
ADUS's Days Sales Outstanding is ranked lower than
92% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 40.40 vs. ADUS: 122.13 )
Ranked among companies with meaningful Days Sales Outstanding only.
ADUS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 76.05  Med: 95.65 Max: 122.13
Current: 122.13
76.05
122.13
Days Payable 4.17
ADUS's Days Payable is ranked lower than
93% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 44.51 vs. ADUS: 4.17 )
Ranked among companies with meaningful Days Payable only.
ADUS' s Days Payable Range Over the Past 10 Years
Min: 4.17  Med: 7.3 Max: 11.4
Current: 4.17
4.17
11.4

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.90
ADUS's 3-Year Average Share Buyback Ratio is ranked higher than
52% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: -2.20 vs. ADUS: -1.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ADUS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -119.5  Med: -1 Max: -0.5
Current: -1.9
-119.5
-0.5

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 5.67
ADUS's Price-to-Net-Current-Asset-Value is ranked higher than
64% of the 67 Companies
in the Global Medical Care industry.

( Industry Median: 8.70 vs. ADUS: 5.67 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
ADUS' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.85  Med: 5.8 Max: 26.29
Current: 5.67
1.85
26.29
Price-to-Tangible-Book 4.88
ADUS's Price-to-Tangible-Book is ranked lower than
68% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 3.75 vs. ADUS: 4.88 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
ADUS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.39  Med: 4.78 Max: 12.07
Current: 4.88
1.39
12.07
Price-to-Intrinsic-Value-Projected-FCF 2.38
ADUS's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
58% of the 97 Companies
in the Global Medical Care industry.

( Industry Median: 1.97 vs. ADUS: 2.38 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ADUS' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.84  Med: 1.24 Max: 2.6
Current: 2.38
0.84
2.6
Price-to-Median-PS-Value 1.45
ADUS's Price-to-Median-PS-Value is ranked lower than
81% of the 226 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. ADUS: 1.45 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ADUS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.16  Med: 0.87 Max: 1.85
Current: 1.45
0.16
1.85
Price-to-Graham-Number 2.30
ADUS's Price-to-Graham-Number is ranked lower than
53% of the 138 Companies
in the Global Medical Care industry.

( Industry Median: 2.41 vs. ADUS: 2.30 )
Ranked among companies with meaningful Price-to-Graham-Number only.
ADUS' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.49  Med: 2.01 Max: 2.97
Current: 2.3
0.49
2.97
Earnings Yield (Greenblatt) % 6.18
ADUS's Earnings Yield (Greenblatt) % is ranked higher than
69% of the 263 Companies
in the Global Medical Care industry.

( Industry Median: 3.84 vs. ADUS: 6.18 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ADUS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -10.1  Med: 7.4 Max: 44.4
Current: 6.18
-10.1
44.4
Forward Rate of Return (Yacktman) % 4.19
ADUS's Forward Rate of Return (Yacktman) % is ranked lower than
70% of the 127 Companies
in the Global Medical Care industry.

( Industry Median: 10.98 vs. ADUS: 4.19 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ADUS' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 1  Med: 2.4 Max: 4.3
Current: 4.19
1
4.3

More Statistics

Revenue (TTM) (Mil) $412.32
EPS (TTM) $ 1.41
Beta-0.53
Short Percentage of Float2.02%
52-Week Range $24.40 - 40.75
Shares Outstanding (Mil)11.62

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 422 453
EPS ($) 1.60 1.91
EPS without NRI ($) 1.60 1.91
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.00%
Dividends per Share ($)
» More Articles for NAS:ADUS

Headlines

Articles On GuruFocus.com
Addus HomeCare to Participate in Baird 2017 Global Healthcare Conference Aug 30 2017 
Addus HomeCare Announces the Addition of Laurie Manning as Chief Human Resource Officer Jul 31 2017 
Addus HomeCare Announces Second-Quarter 2017 Earnings Release and Conference Call Jul 17 2017 
Addus HomeCare Announces First-Quarter 2017 Results And Completion Of A New Senior Secured Credit Fa May 08 2017 
Addus HomeCare Agrees To Acquire One Of The Largest Home-Based Personal Care Providers In New Mexico May 04 2017 
Addus HomeCare Announces First Quarter 2017 Earnings Release and Conference Call Apr 17 2017 
100 Stocks at All-Time Highs | 60 Dividend Stocks Below the Results Feb 19 2013 

More From Other Websites
Edited Transcript of ADUS earnings conference call or presentation 8-Aug-17 1:00pm GMT Sep 14 2017
Addus HomeCare Corp. :ADUS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 6, 2017 Sep 06 2017
Addus HomeCare to Participate in Baird 2017 Global Healthcare Conference Aug 30 2017
Investor Network: Addus HomeCare Corporation to Host Earnings Call Aug 08 2017
Addus HomeCare posts 2Q profit Aug 07 2017
Addus HomeCare Announces Second-Quarter 2017 Financial Results Aug 07 2017
Addus HomeCare Announces the Addition of Laurie Manning as Chief Human Resource Officer Jul 31 2017
Addus HomeCare Announces Second-Quarter 2017 Earnings Release and Conference Call Jul 17 2017
Addus HomeCare Corp. breached its 50 day moving average in a Bearish Manner : ADUS-US : July 17,... Jul 17 2017
Addus HomeCare Corp. – Value Analysis (NASDAQ:ADUS) : July 10, 2017 Jul 10 2017
Addus HomeCare Corp. breached its 50 day moving average in a Bullish Manner : ADUS-US : July 7, 2017 Jul 07 2017
The Zacks Analyst Blog Highlights: Malibu Boats, Addus Homecare, Exelixis, Gran Tierra Energy and... Jul 05 2017
ETFs with exposure to Addus HomeCare Corp. : July 4, 2017 Jul 04 2017
Best Stocks For The Second Half of 2017 Jul 03 2017
New Strong Buy Stocks for June 22nd Jun 22 2017
Edited Transcript of ADUS earnings conference call or presentation 9-May-17 1:00pm GMT Jun 14 2017
ETFs with exposure to Addus HomeCare Corp. : June 8, 2017 Jun 08 2017
New Strong Buy Stocks for June 7th Jun 07 2017
Addus HomeCare Corp. :ADUS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017 Jun 06 2017
No. 1-Ranked Home-Care Stock Giving Therapy To New Buy Zone Jun 01 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}